NIH-funded research R21 grant

Using sound waves to improve cancer treatment for liver tumors

Official title: Acoustic Droplet Initiated Radiosensitivity of Hepatocellular Carcinoma

Funded at Thomas Jefferson University · NIH-10815861 · Data updated 2026-11-12

This study is exploring a new way to make radiation therapy work better for people with liver cancer by using ultrasound to help deliver treatment more effectively, which could lead to better results and longer periods without the cancer getting worse.

More Carcinoma research and trials

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionThomas Jefferson University
NIH-funded
Lab location1 site (Philadelphia, United States)
Project startApril 1, 2023
Project endMarch 31, 2026
Funding year2024
Award (this year)$207,851
NIH project number5R21CA273838-02
Project IDNIH-10815861 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are patients diagnosed with hepatocellular carcinoma who are undergoing or considering radiation therapy.

Less likely to help

Patients with other types of cancer or those who are not candidates for radiation therapy may not benefit from this research.

What this research studies

This research investigates a novel approach to enhance the effectiveness of radiation therapy for hepatocellular carcinoma (HCC), a common and aggressive liver cancer. The study utilizes ultrasound-triggered microbubble destruction to increase the sensitivity of tumors to radiation, potentially improving treatment outcomes. By employing smaller acoustic droplets, the research aims to enhance the delivery and efficacy of the therapy, which has shown promise in preliminary trials. Patients may benefit from improved tumor response rates and longer progression-free survival.

Why it matters

Potential benefit: If successful, this research could lead to more effective treatment options for patients with hepatocellular carcinoma, potentially improving survival rates.

How similar studies have gone: Previous studies have shown promising results using similar ultrasound techniques for enhancing cancer treatment, indicating a potential for success with this novel approach.

Where this research is happening

  • Thomas Jefferson University
    Philadelphia, United States
    Active

Researchers

  • Principal investigator: Eisenbrey, John — Thomas Jefferson University
  • Study coordinator: Eisenbrey, John

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.